Tolga Tanguler - Aug 3, 2022 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Signature
By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Tolga Tanguler
Stock symbol
ALNY
Transactions as of
Aug 3, 2022
Transactions value $
-$1,112,787
Form type
4
Date filed
8/5/2022, 04:15 PM
Previous filing
Jul 7, 2022
Next filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Award $0 +3.63K +206.9% $0.00 5.38K Aug 3, 2022 Direct F1
transaction ALNY Common Stock Sale -$368K -1.75K -32.58% $210.00 3.63K Aug 3, 2022 Direct F2
transaction ALNY Common Stock Tax liability -$307K -1.62K -44.59% $189.76 2.01K Aug 4, 2022 Direct F3
transaction ALNY Common Stock Tax liability -$35.8K -170 -8.45% $210.50 1.84K Aug 4, 2022 Direct F3
transaction ALNY Common Stock Sale -$32K -149 -8.09% $215.03 1.69K Aug 5, 2022 Direct F2, F4
transaction ALNY Common Stock Sale -$86.1K -398 -23.52% $216.21 1.29K Aug 5, 2022 Direct F2, F5
transaction ALNY Common Stock Sale -$95.7K -440 -34% $217.61 854 Aug 5, 2022 Direct F2, F6
transaction ALNY Common Stock Sale -$118K -541 -63.35% $218.71 313 Aug 5, 2022 Direct F2, F7
transaction ALNY Common Stock Sale -$21.7K -99 -31.63% $219.53 214 Aug 5, 2022 Direct F2
transaction ALNY Common Stock Sale -$23.2K -105 -49.07% $220.95 109 Aug 5, 2022 Direct F2
transaction ALNY Common Stock Sale -$1.12K -5 -4.59% $224.00 104 Aug 5, 2022 Direct F2
transaction ALNY Common Stock Sale -$23.4K -104 -100% $225.15 0 Aug 5, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 24, 2021, the reporting person was granted a one-time strategic performance-based stock unit (PSU) award. The People, Culture and Compensation Committee of the Board determined that the performance criterion was met and the PSU award vested as of August 3, 2022.
F2 These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2022.
F3 Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting event.
F4 Sale prices ranged from $214.86 to $215.13.
F5 Sale prices ranged from $216.01 to $217.01.
F6 Sale prices ranged from $217.10 to $218.10
F7 Sale prices ranged from $218.14 to $219.09.